Clearpoint Neuro, Inc. (CLPT)
14.16
-0.19
(-1.35%)
USD |
NASDAQ |
Feb 20, 16:00
14.05
-0.12
(-0.81%)
After-Hours: 20:00
Clearpoint Neuro EPS Diluted (Quarterly) : -0.2072 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.891M |
| Revenue (Quarterly) | 8.861M |
| Total Expenses (Quarterly) | 14.75M |
| Enterprise Value | 424.68M |
| Gross Profit Margin (Quarterly) | 63.20% |
| Profit Margin (Quarterly) | -66.48% |
| Earnings Yield | -5.83% |
| Normalized Earnings Yield | -5.833 |